Shots: Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments, including targeted and immune-therapies for oncology patients. The alliance will support investigations into additional indications and combinations for studies already in the clinic The collaboration will integrate MD Anderson’s clinical trials infrastructure and Sanofi’s pipeline of investigational treatments to […]Read More
Shots: The companies allied to support Takeda’s research stage gene therapy discovery programs across its core therapeutic areas i.e. oncology, rare diseases, neuroscience and gastroenterology The collaboration leverages s Evotec’s gene therapy capabilities along with its drug discovery platform to support Takeda’s programs The partnership will facilitate Takeda’s delivery of transformative therapies for patients, especially […]Read More
Shots: The US FDA has launched Coronavirus Treatment Acceleration Program (CTAP) to expedite the development of safe and effective drugs targeting COVID-19. FDA’s CTAP is a tool to bring new therapies to the patients as soon as possible Under CTAP, FDA is redeploying staff and streamlining processes to hasten the reviews of clinical trial protocols […]Read More
Shots: The public-private collaboration will expand Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules, with the goal to identify compounds with antiviral activity against SARS-CoV-2 As per the collaboration, partners will share the research and development costs and mobilize resources to screen a library of antiviral molecules for activity […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
